COMMUNIQUÉS West-GlobeNewswire
-
Scott VanderWel Joins PCI Synthesis as Business Development Manager
15/11/2017 - 16:15 -
HEALIOS Announces Enrollment of First Patient in Japan in TREASURE Study of MultiStem® Treatment for Ischemic Stroke
15/11/2017 - 16:05 -
Tabula Rasa HealthCare to Participate in the 29th Annual Piper Jaffray Healthcare Conference
15/11/2017 - 16:00 -
Hemispherx Biopharma, Inc. CEO Interviewed on CEOLIVE.TV
15/11/2017 - 15:45 -
Novartis, ASCP and ACS join forces to fight cancer in Ethiopia, Uganda and Tanzania
15/11/2017 - 15:01 -
Immuron Granted US Patent for NASH Treatment
15/11/2017 - 15:00 -
Zosano Pharma to Present at 29th Annual Piper Jaffray Healthcare Conference
15/11/2017 - 15:00 -
CareDx Further Simplifies its Balance Sheet
15/11/2017 - 15:00 -
Progressive Care Reports Stellar Third Quarter Results
15/11/2017 - 14:30 -
Accelerate Diagnostics to Present at the 29th Annual Piper Jaffray Healthcare Conference in New York City
15/11/2017 - 14:30 -
Skyline Medical and Helomics Corporation Sign Joint Venture Term Sheet to Build-out and Commercialize the D-CHIP™ platform
15/11/2017 - 14:30 -
Hemispherx Biopharma Announces Corporate Progress and Financial Results for the Nine Months Ended September 30, 2017
15/11/2017 - 14:30 -
Progressive Care Reports Stellar Third Quarter Results
15/11/2017 - 14:30 -
Onconova Therapeutics Announces Publication of Results from Phase 1/2 Study of Rigosertib in Patients with Myelodysplastic Syndromes (MDS) and MDS Progressed to Acute Myeloid Leukemia
15/11/2017 - 14:30 -
Abeona Reports Third Quarter 2017 Financial Results and Recent Business Highlights
15/11/2017 - 14:25 -
ADMA Biologics Further Enhances Intellectual Property Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Compositions
15/11/2017 - 14:08 -
Medovex Corporation Initiates Move to List on the OTCQB Market
15/11/2017 - 14:00 -
Preclinical Studies with MyoKardia’s Mavacamten Demonstrate Evidence of Reduced Contractility and Improved Left Ventricular Compliance
15/11/2017 - 14:00 -
MEDITE Cancer Diagnostics Appoints Joel Kanter To Its Board As An Independent Director
15/11/2017 - 14:00
Pages